Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment

MLA

González JM, et al. “Patient and Physician Preferences for Anticancer Drugs for the Treatment of Metastatic Colorectal Cancer: A Discrete-Choice Experiment.” Cancer Management and Research, vol. ume 9, Apr. 2017, pp. 149–58. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.4068716de6454f3e9beb2ced2efc8839&authtype=sso&custid=ns315887.

APA

González JM, Ogale S, Morlock R, Posner J, Hauber B, Sommer N, & Grothey A. (2017). Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment. Cancer Management and Research, ume 9, 149–158.

Chicago

González JM, Ogale S, Morlock R, Posner J, Hauber B, Sommer N, and Grothey A. 2017. “Patient and Physician Preferences for Anticancer Drugs for the Treatment of Metastatic Colorectal Cancer: A Discrete-Choice Experiment.” Cancer Management and Research ume 9 (April): 149–58. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.4068716de6454f3e9beb2ced2efc8839&authtype=sso&custid=ns315887.